Silica for Paint: Matting, Anti-Settling and Rheology Functions Explained

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silicon Nitride vs Silicon Dioxide: Properties and Applications Compared
  • Keywords: silicon dioxide supplier
  • Published: 2026-11-20 11:12:41
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Silica Gel Beads: Types, Sizes, Indicating vs Non-Indicating and Uses

What Is Amorphous Silica? Types, Safety Profile and Industrial Uses
Why Is Silicon Dioxide a Covalent Network Solid? Structure and Properties Explained
The pathway of administration of MSN during treatment contains oral, inhalation, intravenous, intramuscular and intraperitoneal injections. Regardless of the administration approach, it is expected that the MSNs will be maximally enriched at the lesion site. However, in those delivery systems, MSNs-based formulations tend to distribute throughout the body. 312, 313 Some studies have shown that MSNs accumulate largely in the liver and spleen, 312, 314, 315 and that the high concentration of MSNs at these normal organ tissues not only severely reduces the therapeutic efficacy of MSNs-based formulations, but also induces some potentially toxic influences on the RES. Consequently, boosting the active targeting skill of MSNs has substantial implications for facilitating preclinical studies of MSNs-based therapeutic system.
What Is 4N Silica? Purity Standards, Impurity Limits and Uses
Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.
Silica Exposure Limits: OSHA, ACGIH and EU Limits Compared

What Is Silicon Oxide? SiO vs SiO₂ Differences and Applications Explained

What is silica (SiO₂)?

silica in cosmetics

What is the difference between fumed silica and precipitated silica?

silicon oxide anode

What drives silica raw material prices?

silica gel manufacturer Bioimaging is a potent tool that can be used for the diagnosis of diverse diseases, and the NPs-based contrast agents have become the research frontier in the field of bioimaging. 350, 351, 352 The integration of contrast agents onto MSNs can address the problems of insufficient stability and poor water solubility of contrast agents, along with the targeting ligand modification on the surface of MSNs can enhance the enrichment of contrast agents at selected sites. 353, 354 In magnetic resonance imaging (MRI), the mesoporous structure of MSNs allows the free access of water molecules in the MSNs matrix, hence enhancing the contrast performance of Fe/Mn/Gd-involved MSNs-based nanoprobes. 353 In fluorescence imaging (FL), the protective effect of MSNs can prevent the dye self-aggregation or self-quenching, improves the photobleaching resistance property and improves quantum yields. 354 Positron emission tomography (PET) imaging is a noninvasive imaging modality and often applied in illness diagnosis. The molecular probes used in PET imaging need to be labeled with the radioisotopes, e.g., 64 Cu and 18 F. The introduction of MSNs matrix offers great potential in extending the half-life of radioisotopes. 355, 356, 357 In photoacoustic (PA) imaging, the PA contrast agents such as polydopamine (PDA) NPs, 358 Cy754, 359 and ICG 360 have also been revealed to be protected by MSNs matrix, hence to gain desirable PA signals. In addition to those listed above, MSNs have been widely applied in ultrasound imaging, 361, 362 X-ray computed tomography (CT) imaging, 168, 363 or multimodality imaging. 364, 365, 366

Cite this article: Silica Raw Materials News. "Silica Gel Column Chromatography: How It Works and How to Choose the Silica ." Published 2026-11-20 11:12:41. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.